Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01560338 · ClinicalTrials.gov registry record
Hypothermia's Impact on Pharmacology
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 41
- Enrollment target
NCT01560338: Completed study, sponsored by Children's Hospital of Philadelphia.
NCT01560338 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01560338 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The purpose of the study will help us understand the complex interaction between hypothermia (cooling) and pharmacogenetics (how specific genes effect how drugs are handled), and their impact on how routinely given sedation drug are broken down and used by the body when given to children after cardiac arrest (when heart stops pumping blood) and are critically ill.
Primary Outcome
The objective of this aim is to identify the physiologic manifestations of cardiac arrest and MODS that underlie the variability in morphine and midazolam pharmacokinetics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-03 |
| Est. Completion | 2018-01-28 |
What the finished NCT01560338 record still lists
NCT01560338 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01560338 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01560338 about?
NCT01560338 is a clinical study titled "Hypothermia's Impact on Pharmacology". The purpose of the study will help us understand the complex interaction between hypothermia (cooling) and pharmacogenetics (how specific genes effect how drugs are handled), and their impact on how routinely given sedation drug are broken down and used by the body when given to children after cardi...
What is the current status of trial NCT01560338?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2012-03. Estimated completion is 2018-01-28.
Who is sponsoring clinical trial NCT01560338?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia